AARTI DRUGS Financial Statement Analysis
|
||
The Revenues of AARTI DRUGS have increased by 9.14% YoY .
The Earnings Per Share (EPS) of AARTI DRUGS has decreased by -18.88 % YoY. |
REVENUES |
OPERATING MARGIN |
PROFIT AFTER TAX |
EPS |
ROCE |
AARTI DRUGS Last 5 Annual Financial Results
[BOM: 524348|NSE : AARTIDRUGS]
Consolidated | Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 |
---|---|---|---|---|---|
Revenues | ₹2,716 Cr | ₹2,489 Cr | ₹2,155 Cr | ₹1,806 Cr | ₹1,561 Cr |
Expenses | ₹2,407 Cr | ₹2,156 Cr | ₹1,714 Cr | ₹1,541 Cr | ₹1,350 Cr |
Operating Profit (Excl OI) | ₹309 Cr | ₹333 Cr | ₹440 Cr | ₹266 Cr | ₹211 Cr |
Other Income | ₹2.19 Cr | ₹11 Cr | ₹4.53 Cr | ₹1.48 Cr | ₹2.41 Cr |
Interest | ₹37 Cr | ₹24 Cr | ₹26 Cr | ₹37 Cr | ₹44 Cr |
Depreciation | ₹50 Cr | ₹50 Cr | ₹50 Cr | ₹49 Cr | ₹43 Cr |
Profit Before Tax | ₹224 Cr | ₹270 Cr | ₹369 Cr | ₹185 Cr | ₹131 Cr |
Profit After Tax | ₹166 Cr | ₹205 Cr | ₹280 Cr | ₹141 Cr | ₹90 Cr |
Consolidated Net Profit | ₹166 Cr | ₹205 Cr | ₹280 Cr | ₹141 Cr | ₹90 Cr |
Earnings Per Share (Rs) | ₹17.96 | ₹22.14 | ₹30.09 | ₹60.69 | ₹38.06 |
PAT Margin (%) | 6.12 | 8.24 | 13.01 | 7.83 | 5.75 |
ROE(%) | 14.93 | 21.03 | 35.81 | 23.65 | 17.97 |
ROCE(%) | 15.49 | 20.75 | 34.52 | 21.39 | 17.01 |
Total Debt/Equity(x) | 0.51 | 0.52 | 0.38 | 0.58 | 0.93 |
Key Financials |
||
Market Cap | : | ₹ 4,629.5 Cr |
Revenue (TTM) | : | ₹ 2,651.0 Cr |
Net Profit(TTM) | : | ₹ 180.5 Cr |
EPS (TTM) | : | ₹ 19.6 |
P/E (TTM) | : | 25.7 |
Industry Peers & Returns | 1W | 1M | 1Y |
AARTI DRUGS | 2.1% | 10.6% | 19.1% |
SUN PHARMACEUTICAL INDUSTRIES | -2.3% | -6.5% | 55.3% |
CIPLA | 4.1% | -4.8% | 55.6% |
DR REDDYS LABORATORIES | 4% | 0.8% | 29.4% |
ZYDUS LIFESCIENCES | -1.2% | -5.2% | 83.9% |
DIVIS LABORATORIES | 7.8% | 17.4% | 20.3% |
MANKIND PHARMA | 1.3% | 7% | NA |
TORRENT PHARMACEUTICALS | 3.9% | 5.1% | 66.1% |
LUPIN | 0.6% | 0.5% | 127.2% |
AARTI DRUGS Revenues
[BOM: 524348|NSE : AARTIDRUGS]
Y-o-Y | 9.14 % |
5 Yr CAGR | 14.85 % |
Years | Revenues | % Change | |
---|---|---|---|
Mar2023 | ₹2,716 Cr | 9.14 | |
Mar2022 | ₹2,489 Cr | 15.49 | |
Mar2021 | ₹2,155 Cr | 19.31 | |
Mar2020 | ₹1,806 Cr | 15.71 | |
Mar2019 | ₹1,561 Cr | - |
AARTI DRUGS Operating Profit
[BOM: 524348|NSE : AARTIDRUGS]
Y-o-Y | -6.96 % |
5 Yr CAGR | 10.06 % |
Years | Operating Profit | % Change | |
---|---|---|---|
Mar2023 | ₹309 Cr | -6.96 | |
Mar2022 | ₹333 Cr | -24.47 | |
Mar2021 | ₹440 Cr | 65.86 | |
Mar2020 | ₹266 Cr | 25.89 | |
Mar2019 | ₹211 Cr | - |
Operating Margins | |
---|---|
Y-o-Y | -14.75 % |
5 Yr CAGR | -4.18 % |
Years | Operating Margin% | % Change | |
---|---|---|---|
Mar2023 | 11.39% | -14.75 | |
Mar2022 | 13.36% | -34.64 | |
Mar2021 | 20.44% | 39.05 | |
Mar2020 | 14.7% | 8.81 | |
Mar2019 | 13.51% | - |
AARTI DRUGS Profit After Tax
[BOM: 524348|NSE : AARTIDRUGS]
Y-o-Y | -18.89 % |
5 Yr CAGR | 16.67 % |
Years | Profit After Tax | % Change | |
---|---|---|---|
Mar2023 | ₹166 Cr | -18.89 | |
Mar2022 | ₹205 Cr | -26.88 | |
Mar2021 | ₹280 Cr | 98.31 | |
Mar2020 | ₹141 Cr | 57.55 | |
Mar2019 | ₹90 Cr | - |
PAT Margins | |
---|---|
Y-o-Y | -25.73 % |
5 Yr CAGR | 1.57 % |
Years | PAT Margin(%) | % Change | |
---|---|---|---|
Mar2023 | 6.12 % | -25.73 | |
Mar2022 | 8.24 % | -36.66 | |
Mar2021 | 13.01 % | 66.16 | |
Mar2020 | 7.83 % | 36.17 | |
Mar2019 | 5.75 % | - |
AARTI DRUGS Earnings Per Share (EPS)
[BOM: 524348|NSE : AARTIDRUGS]
Y-o-Y | -18.88 % |
5 Yr CAGR | -17.12 % |
Years | EPS | % Change | |
---|---|---|---|
Mar2023 | ₹18 | -18.88 | |
Mar2022 | ₹22 | -26.42 | |
Mar2021 | ₹30 | -50.42 | |
Mar2020 | ₹61 | 59.46 | |
Mar2019 | ₹38 | - |
AARTI DRUGS Return on Capital Employed (ROCE)
[BOM: 524348|NSE : AARTIDRUGS]
Y-o-Y | -25.35 % |
5 Yr CAGR | -2.31 % |
Years | ROCE | % Change | |
---|---|---|---|
Mar2023 | 15.49% | -25.35 | |
Mar2022 | 20.75% | -39.89 | |
Mar2021 | 34.52% | 61.38 | |
Mar2020 | 21.39% | 25.75 | |
Mar2019 | 17.01% | - |
AARTI DRUGS Share Price vs Sensex
Current Share Price | : | ₹503.8 |
Current MarketCap | : | ₹ 4,629.5 Cr |
Updated EOD on | : | Apr 26,2024 |
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
AARTI DRUGS | 2.1% |
10.6% |
19.1% |
SENSEX | 0.9% |
1.5% |
23.6% |
AARTI DRUGS related INDICES
BSE Indices | 1W | 1M | 1Y |
---|---|---|---|
S&P BSE 250 SMALLCAP | 4.1% | 11.8% | 66.8% |
S&P BSE MIDSMALLCAP | 4% | 9.7% | 67.3% |
S&P BSE SMALL CAP | 4% | 11.6% | 67.3% |
S&P BSE 400 MIDSMALLCAP | 3.8% | 9.1% | 62% |
S&P BSE HEALTHCARE | 3% | 4% | 55.2% |
You may also like the below Video Courses
FAQ about AARTI DRUGS Financials
How the annual revenues of AARTI DRUGS have changed ?
The Revenues of AARTI DRUGS have increased by 9.14% YoY .
How the Earnings per Share (EPS) of AARTI DRUGS have changed?
The Earnings Per Share (EPS) of AARTI DRUGS has decreased by -18.88 % YoY .
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs